Stock Fundamentals

Company Information

Company Name
Kenvue Inc.
Sector
Consumer Defensive
Industry
Household & Personal Products
Exchange
NYSE
ISIN: US49177J1025
CIK: 0001944048
CUSIP: 49177J102
Currency: USD
Full Time Employees: 21,780
Phone: 908 874 1200
Fiscal Year End: December
IPO Date: May 04, 2023
Description:

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Address:

1 Kenvue Way, Summit, NJ, United States, 07901

Directors & Officers

Name Title Year Born
Mr. Kirk L. Perry CEO & Director 1967
Mr. Michael P. Wondrasch Chief Technology & Data Officer 1969
Mr. Matthew Orlando General Counsel 1977
Mr. Carlton Lawson Group President of Europe, Middle East & Africa 1969
Ms. Heather R. Howlett Interim CFO & Chief Accounting Officer 1978
Ms. Meredith Stevens Chief Operations Officer 1963
Dr. Caroline Tillett Ph.D. Chief Scientific Officer 1972
Ms. Sofya Tsinis Head of Investor Relations NA
Mr. Jonathan Halvorson Chief Digital & Marketing Officer 1983
Mr. Anil Agarwal Head of Total Rewards NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 17, 2026 Kevin Hern N/A Sale N/A $17.77 N/A
Mar 13, 2026 Gilbert Ray Cisneros, Jr. N/A Sale N/A $17.51 N/A
Feb 10, 2026 Gilbert Ray Cisneros, Jr. N/A Purchase N/A $18.34 N/A
Jan 29, 2026 Ro Khanna N/A Purchase N/A $17.19 N/A
Jan 09, 2026 Gilbert Ray Cisneros, Jr. N/A Sale N/A $16.82 N/A
Jan 06, 2026 Ro Khanna N/A Sale N/A $16.74 N/A
Dec 12, 2025 Jeffrey C Smith N/A Purchase 3.20M $17.37 $55.58M
Dec 11, 2025 Jeffrey C Smith N/A Purchase 3.18M $17.43 $55.39M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 234.95M Dec 31, 2025 12.24% $0.06 0.69%
BlackRock Inc 145.30M Mar 31, 2026 7.57% $0.04 -8.93%
FMR Inc 135.09M Mar 31, 2026 7.04% $0.12 43.54%
Vanguard Capital Management, LLC 124.42M Mar 31, 2026 6.48% $0.05 0.00%
State Street Corp 119.57M Mar 31, 2026 6.23% $0.07 0.59%
Vanguard Portfolio Management, LLC 92.46M Mar 31, 2026 4.82% $0.08 0.00%
Pentwater Capital Management LP 52.00M Mar 31, 2026 2.71% $4.65 -8.32%
Geode Capital Management, LLC 51.27M Mar 31, 2026 2.67% $0.05 2.82%
Massachusetts Financial Services Company 49.74M Mar 31, 2026 2.59% $0.29 -27.37%
Independent Franchise Partners LLP 49.21M Mar 31, 2026 2.56% $5.94 2.21%
NORGES BANK 43.88M Dec 31, 2025 2.29% $0.08 70.88%
Millennium Management LLC 31.80M Mar 31, 2026 1.66% $0.23 45.87%
Starboard Value LP 27.31M Mar 31, 2026 1.42% $10.29 0.00%
D. E. Shaw & Co LP 26.28M Mar 31, 2026 1.37% $0.27 -0.57%
Balyasny Asset Management LLC 24.56M Mar 31, 2026 1.28% $0.55 1.42%
Dimensional Fund Advisors, Inc. 22.27M Mar 31, 2026 1.16% $0.08 0.89%
The Goldman Sachs Group Inc 22.12M Mar 31, 2026 1.15% $0.04 37.17%
Morgan Stanley - Brokerage Accounts 21.37M Mar 31, 2026 1.11% $0.02 24.05%
HBK INVESTMENTS L P 21.00M Mar 31, 2026 1.09% $3.67 728.40%
UBS Group AG 20.76M Mar 31, 2026 1.08% $0.05 -50.27%

Shares Statistics

Shares Outstanding: 1.92B
Shares Float: 1.92B
% Insiders: 5.10%
% Institutions: 9,479.70%
Short % Float: 3.54%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 FPA Crescent 136.00M 7.08% ▲ 0.00% Sep 30, 2025
2 Vanguard Total Stock Mkt Idx Inv 61.09M 3.18% ▲ 0.38% Apr 30, 2026
3 Vanguard 500 Index Investor 49.68M 2.59% ▲ 1.83% Apr 30, 2026
4 Vanguard Mid Cap Index Institutional 41.50M 2.16% ▲ 0.23% Apr 30, 2026
5 iShares Core S&P 500 ETF 25.24M 1.31% ▲ 0.31% May 29, 2026
6 Fidelity 500 Index 24.55M 1.28% ▲ 0.35% Apr 30, 2026
7 State Street® SPDR® S&P 500® ETF 23.16M 1.21% ▲ 0.11% May 31, 2026
8 State Street® SPDR® S&P® Dividend ETF 19.75M 1.03% ▲ 0.00% May 31, 2026
9 State Street®CnsmrStpSelSectSPDR®ETF 18.86M 0.98% ▼ 0.28% May 31, 2026
10 VanEck Morningstar Wide Moat 17.97M 0.94% ▼ 0.74% Mar 31, 2026

Valuation Metrics

Enterprise Value: $45.13B
Trailing P/E: 23.19
Forward P/E: 16.95

Financial Highlights

Market Cap: $37.40B
EBITDA: $3.47B
P/E Ratio: $23.19
PEG Ratio: $1.61
Book Value: $5.53
Dividend/Share: $0.83
Dividend Yield: 4.32%
Earnings/Share: $0.84
Profit Margin: 10.61%
Operating Margin: 21.62%
ROA (TTM): 7.07%
ROE (TTM): 15.70%
Revenue (TTM): $15.29B
Revenue/Share (TTM): $7.97
Earnings Growth (YOY): 46.90%
Revenue Growth (YOY): 4.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 0.96x 0.78x 0.60x 7.13x 2.86x
2024-12-31 0.96x 0.88x 0.62x 4.27x 3.46x
2023-12-31 1.12x 0.74x 0.60x 7.02x 2.62x
2022-12-31 1.50x 0.45x 0.27x N/A 2.73x
2021-12-31 1.22x 0.00x 0.27x N/A 0.01x
2020-12-31 0.61x 0.01x 0.37x N/A 0.04x
2019-12-31 N/A N/A N/A N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about KVUE.US!